B-cell non-Hodgkin's lymphoma
Clinical trials for B-cell non-Hodgkin's lymphoma explained in plain language.
Never miss a new study
Get alerted when new B-cell non-Hodgkin's lymphoma trials appear
Sign up with your email to follow new studies for B-cell non-Hodgkin's lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can an experimental antibody boost chemo's power against lymphoma?
Disease control OngoingThis Phase 2 trial tests whether adding an experimental antibody called JS203 to standard chemotherapy regimens can shrink tumors in people with B-cell non-Hodgkin's lymphoma, a cancer of immune cells. The study enrolls adults aged 18 to 80 whose cancer cells carry the CD20 marke…
Matched conditions: B-CELL NON-HODGKIN'S LYMPHOMA
Phase 2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New pill shows promise for tough blood cancers in early trial
Disease control OngoingThis early-stage study tests an oral drug called MK-1026 in 12 Chinese adults with blood cancers (like lymphoma or leukemia) that returned or didn't respond to prior therapies. The main goals are to check the drug's safety and how the body processes it. Researchers will also look…
Matched conditions: B-CELL NON-HODGKIN'S LYMPHOMA
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
15-Year safety check for caribou cell therapy patients
Knowledge-focused By invitation onlyThis study follows about 150 people who previously received Caribou cell therapy for blood cancers like lymphoma or leukemia. Researchers will check for long-term side effects and overall survival for up to 15 years after treatment. No new treatment is given—this is just observat…
Matched conditions: B-CELL NON-HODGKIN'S LYMPHOMA
Sponsor: Caribou Biosciences, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC